ISOREA AB received investment from Linnéa Capital AB
July 20, 2023 at 12:14 pm
ISOREA AB is very happy to announce that we have received an investment from Linnéa Capital AB. This investment will help ISOREA AB to start its IVDR application procedure of the KIT designed to detect Early Alzheimer's by a sensitive and affordable blood test. Our KIT has the potential to detect Alzheimer's disease at Early stage or Mild Cognitive Impairment (MCI) stage and thereby helping patients to start medical interventions using new age drugs developed by other providers for patients at MCI stage. This KIT is also vital for blood screening at the Blood Banks before transfusion to the recipients, as a preventative measure from receiving isoaspartate containing bad albumin.